PRPO

Precipio (PRPO)

Precipio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRPO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRPO	Precipio Inc
2024/05/07	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRPO	Precipio Inc
2024/05/07	06 : 00	GlobeNewswire Inc.	Precipio Secures a short-term $500K Credit Facility	NASDAQ:PRPO	Precipio Inc
2024/03/26	06 : 00	GlobeNewswire Inc.	Precipio Announces Year end 2023 Shareholder Update Call	NASDAQ:PRPO	Precipio Inc
2024/02/14	00 : 00	GlobeNewswire Inc.	Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY	NASDAQ:PRPO	Precipio Inc
2024/02/07	00 : 00	GlobeNewswire Inc.	Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer	NASDAQ:PRPO	Precipio Inc
2024/01/24	00 : 00	GlobeNewswire Inc.	Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter	NASDAQ:PRPO	Precipio Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRPO	Precipio Inc
2024/01/18	00 : 30	GlobeNewswire Inc.	Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	NASDAQ:PRPO	Precipio Inc
2024/01/05	06 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2024/01/05	06 : 30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2024/01/03	07 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRPO	Precipio Inc
2024/01/02	23 : 00	GlobeNewswire Inc.	Precipio Announces Christina Valauri joins the Board of Directors	NASDAQ:PRPO	Precipio Inc
2023/12/15	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRPO	Precipio Inc
2023/12/15	06 : 30	GlobeNewswire Inc.	Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024	NASDAQ:PRPO	Precipio Inc
2023/11/17	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRPO	Precipio Inc
2023/11/17	07 : 00	GlobeNewswire Inc.	Precipio Announces Q3-2023 Shareholder Update Call	NASDAQ:PRPO	Precipio Inc
2023/11/14	06 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRPO	Precipio Inc
2023/11/01	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2023/10/27	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2023/10/27	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2023/10/27	05 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2023/10/18	22 : 00	GlobeNewswire Inc.	Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022	NASDAQ:PRPO	Precipio Inc
2023/10/07	05 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRPO	Precipio Inc
2023/10/03	23 : 00	GlobeNewswire Inc.	Precipio’s Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023	NASDAQ:PRPO	Precipio Inc
2023/09/28	22 : 00	GlobeNewswire Inc.	Precipio Continues to Sign New HemeScreen™ Customers	NASDAQ:PRPO	Precipio Inc
2023/09/26	00 : 00	GlobeNewswire Inc.	Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven	NASDAQ:PRPO	Precipio Inc
2023/09/22	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRPO	Precipio Inc
2023/09/15	05 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc
2023/09/15	05 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRPO	Precipio Inc